Development of a novel monoclonal antibody to B7-H4: Characterization and biological activity

European Journal of Medical Research

Volumn 16, Issue 7, 2011, Pages 295-302

  Qian, Y ^a,b   Shen, L ^a   Xu, C ^a   Wu, Z ^a   Brockmeyer, N H ^c   Altmeyer, P ^c   Wu, N ^a   Yao, Hang Ping ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

B7 H4; Biological activity; Immunologic techniques; Monoclonal antibody

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7 H4; PROTEIN B7 H4; UNCLASSIFIED DRUG; B7 H4 MONOCLONAL ANTIBODY; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL MEMBRANE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREGULATION; LEUKEMIA CELL; MOUSE; NONHUMAN; T LYMPHOCYTE; WESTERN BLOTTING; ANIMAL EXPERIMENT; BIOLOGICAL ACTIVITY; HYBRIDOMA; LYMPHOCYTE DIFFERENTIATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD80; CYTOKINES; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASMS;

EID: 80051696587     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, Chapoval AI, Flies DB, Bajorath J, Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 2003; 18: 849-861
2. Chen L. Co-inhibitory molecules of the B7- CD28 family in the control of T cell immunity. Nature Rev Immunol. 2004; 4: 336-347 (Pubitemid 38649276)
3. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA. 2003; 100: 10388-10392
4. Prasad DVR, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 2003; 18: 863-873 (Pubitemid 36776433)
5. Salceda S, Tang T, Kmet M, Munteanu A, Ghosh M, Macina R, Liu W, Pilkington G, Papkoff J. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res. 2005; 306: 128-141 (Pubitemid 40692778)
6. Tringler B, Zhuo S, Pilkington G, Torkko KC, Singh M, Lucia MS, Heinz DE, Papkoff J, Shroyer KR. B7-h4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res. 2005; 11: 1842-1848 (Pubitemid 40471848)
7. Choi IH, Zhu G, Sica GL, Strome SE, Cheville JC, Lau JS, Zhu Y, Flies DB, Tamada K, Chen L. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol. 2003; 171: 4650-4654 (Pubitemid 37310581)
8. Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Nati Acad Sci USA. 2006; 103: 10391-10396
9. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA, Scardino PT, Sharma P, Allison JP. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA. 2007; 104: 19458-19463
10. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer. 2006; 53: 143-151 (Pubitemid 43994236)
11. Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med. 2006; 203: 871-881
12. Simon I, Zhuo S, Corral L, Diamandis EP, Sarno MJ, Wolfert RL, Kim NW. B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer. Cancer Res. 2006; 66: 1570-1575
13. Thompson RH, Zang X, Lohse CM, Leibovich BC, Slovin SF, Reuter VE, Cheville JC, Blute ML, Russo P, Kwon ED, Allison JP. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. Cancer Res. 2008; 68: 6054-6058
14. Mugler KC, Singh M, Tringler B, Torkko KC, Liu W, Papkoff J, Shroyer KR. B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration. Appl Immunohistochem Mol Morphol. 2007; 15(4): 363-370 (Pubitemid 350307840)
15. Qian Y, Shen L, Cheng LF, Wu ZG, Yao HP. B7-H4 expression in various tumors determined using a novel developed monoclonal antibody. Clin Exp Med. 2010; [printed in head]
16. Yao HP, Luo YL, Feng L, Cheng LF, Lu Y, Li W, Wang MH. Agonistic monoclonal antibodies potentiate tumorigenic and invasive activities of splicing variant of the RON receptor tyrosine kinase. Cancer Biol Ther. 2006; 5: 1179-1186 (Pubitemid 44772234)
17. Nelson PN, Reynolds GM, Waldron EE, Ward E, Giannopoulos K, Murray PG. Monoclonal antibodies. Molecular Pathology. 2000; 53 : 111-117
18. Qian Y, Yao HP, Cheng LF, Shen L, Gu LJ, Tao L, Zhang LH. Expression and identification of recombinant mouse gene B7-H4. Journal of Zhejiang University (medical sciences). 2009; 38: 117-124
19. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998; 11: 155-168 (Pubitemid 28144151)
20. Park GB, Song H, Kim YS, Sung M, Ryu JW, Lee HK, Cho DH, Kim D, Lee WJ, Hur DY. Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines. Immunology. 2009; 128(3): 360-368
21. Guin S, Yao HP, Wang MH. RON receptor tyrosine kinase as a target for delivery of chemodrugs by antibody directed pathway for cancer cell cytotoxicity. Mol Pharm. 2010; 7(2): 386-397
22. Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR. B7-H4 overexpression in ovarian tumors. Gynecol Oncol. 2006; 100: 44-52 (Pubitemid 41815048)
23. Miyatake T, Tringler B, Liu W, Liu SH, Papkoff J, Enomoto T, Torkko KC, Dehn DL, Swisher A, Shroyer KR. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol. 2007; 106: 119-127
24. Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S, Kong B. B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer. 2009; 19: 1481-1486
25. Jiang J, Zhu Y, Wu C, Shen Y, Wei W, Chen L, Zheng X, Sun J, Lu B, Zhang X. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer. Cancer Immunol Immunother. 2010; 59(11): 1707-1714
26. Azzoni C, Bottarelli L, Cecchini S, Lagrasta C, Pizzi S, D'Adda T, Tamburini E, Rindi G, Bordi C. Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors. Virchows Arch. 2011; [Epub ahead of print]
27. Zynek-Litwin M, Kuzniar J, Nocen-Rychlewska B, Kusztal M, Klinger M. An inconspicuous insect bite as the cause of sepsis in a patient treated with infliximab due to rheumatoid arthritis. Adv Med Sci. 2011; [Epub ahead of print]